SCHEMBL12759290

SCHEMBL12759290

CCCCOc1ccc(OCc2ccc(C3CCC(CCC)OC3)cc2)c(F)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 7/20 0.46
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
CRHBP P24387 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
CRHR2 Q13324 1/20 0.36
RAB9A P51151 1/20 0.33
PSEN1 P49768 5/20 0.33
PPARG P37231 3/20 0.33
PTGES O14684 3/20 0.33
SPHK1 Q9NYA1 3/20 0.32
HTR1A P08908 2/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12759289 0.96 ALOX5 (0.46) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL12759288 0.95 ALOX5 (0.45) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL12759276 0.95 ALOX5 (0.46) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL12759279 0.93 ALOX5 (0.45) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL12759287 0.93 ALOX5 (0.41) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL12759268 0.92 ALOX5 (0.48) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL12759282 0.92 ALOX5 (0.44) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL15340142 0.91 ALOX5 (0.40) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL12759272 0.90 ALOX5 (0.46) ALOX5SMN1; SMN2MEN1MAPTCRHBP
SCHEMBL12759257 0.90 ALOX5 (0.46) ALOX5SMN1; SMN2MEN1MAPTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2272837-B1 LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2014-12-17 EP disclosed
US-7914862-B2 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device CHISSO CORPORATION (JP) 2011-03-29 US disclosed
US-7914862-B2 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device CHISSO CORPORATION (JP) 2011-03-29 US disclosed
EP-2272837-A1 LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE Chisso Corporation (JP) 2011-01-12 EP disclosed
US-20090278088-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2009-11-12 US disclosed
US-20090278088-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090278088-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE OCIAD2, OCIAD1, CCDC22 ALOX5 1008/4885SMN1; SMN2 4615/4885MEN1 3564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.